University of Florida College of Medicine-Jacksonville

Labroots Announces its 11th Annual Event in the Cancer Research & Immuno-Oncology Week Virtual Series on October 3-5, 2023

Retrieved on: 
Thursday, September 28, 2023

YORBA LINDA, Calif., Sept. 28, 2023 /PRNewswire-PRWeb/ -- Yorba Linda, CA (September 28, 2023) -Labroots, the leading scientific social networking website offering premier, interactive virtual and hybrid events and webinars, is hosting its 11th annual Cancer Research & Immuno-Oncology Week conference on October 3-5, 2023, free to attend.

Key Points: 
  • Cancer Research & Immuno-Oncology Week 2023 continues to deliver a prestigious forum for some of the brightest minds in the fields of cancer research and immuno-oncology disciplines.
  • I'm excited to share our work at the 11th annual Labroots Cancer Research & Immuno-Oncology Week conference where the invaluable discussions will help shape the nature of our studies moving forward."
  • Use the hashtag #LRcancer to follow the conversation and connect with members of the global Cancer & Oncology Research community!
  • Follow @Cancer_LR on Twitter and @CancerResearchandOncology.LR on Facebook to connect with our specialist Cancer & Oncology writers and stay up to date with the latest news in Cancer & Oncology Research.

Florida Cancer Specialists & Research Institute Welcomes Hematologist and Medical Oncologist Raphael Bosse, MD, PhD to Collier County

Retrieved on: 
Tuesday, September 12, 2023

FORT MYERS, Fla., Sept. 12, 2023 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) is pleased to announce that Board-certified hematologist and medical oncologist Raphael Bosse, MD, PhD has joined the statewide practice.

Key Points: 
  • FORT MYERS, Fla., Sept. 12, 2023 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) is pleased to announce that Board-certified hematologist and medical oncologist Raphael Bosse, MD, PhD has joined the statewide practice.
  • He is providing care to patients at the Naples-Goodlette location , 1100 Goodlette Road N., Naples, Florida 34102.
  • Dr. Bosse received his medical degree and doctorate in Molecular Cell Biology & Hematology from the University of Florida College of Medicine.
  • "We are delighted to welcome Dr. Bosse to our team of cancer experts in Collier County," said FCS Chief Executive Officer Nathan H. Walcker .

Berkshire Biomedical Announces Two Poster Presentations at the CPDD 85th Annual Scientific Meeting

Retrieved on: 
Tuesday, June 20, 2023

DALLAS, June 20, 2023 /PRNewswire/ -- Berkshire Biomedical Corporation ("Berkshire" or the "Company"), focused on developing its proprietary drug dispensing technology to enhance patient wellness, announced today that two posters on the Company's Computerized Oral Prescription Administration System (COPA) were presented yesterday at The College on Problems of Drug Development (CPDD) 85th Annual Scientific Meeting, currently being held through Wednesday, June 21, 2023 in Denver, CO. The COPA is a novel, oral liquid dispensing system specifically designed to deliver accurate and precise doses of controlled and non-controlled prescription medications to only an Authenticated Intended User (AIU™), upon confirmation of dual biometric identifications, (fingerprint and dentition), with the goal of enhancing patient wellness and providing remote monitoring.

Key Points: 
  • "The opportunity to present two posters at such an important scientific meeting speaks volumes about the potential technological strength and versatility of our proprietary, cloud-based, healthcare-enabled COPA device," stated John Timberlake, Chief Executive Officer of Berkshire.
  • "COPA may significantly increase the safety and effectiveness of take-home methadone medication administration for opioid use disorder, thus potentially reducing patient burden, improving clinic operational efficiencies, and enhancing patient outcomes.
  • Details of the poster presentations are below:
    Poster Author & Poster Number: John Timberlake, et al (Poster # 3007513)
    Over 500,000 people in the US receive oral liquid methadone to treat opioid use disorder, which, by law, currently is only accessible from federally certified opioid treatment programs.
  • This device may reduce barriers to treatment for methadone patients, improve clinic efficiency, and expand the flexibility of settings for methadone administration.

Aspira Women’s Health Appoints Dr. Winfred Parnell to its Board of Directors

Retrieved on: 
Monday, June 5, 2023

AUSTIN, Texas, June 05, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced the appointment of Dr. Winfred Parnell as a new independent director on the Aspira Board of Directors, effective June 1, 2023.

Key Points: 
  • AUSTIN, Texas, June 05, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced the appointment of Dr. Winfred Parnell as a new independent director on the Aspira Board of Directors, effective June 1, 2023.
  • “We are thrilled to welcome Dr. Parnell to our Board of Directors.
  • “As we expand our product portfolio, Dr. Parnell’s clinical, business, and board experience will be invaluable.”
    Dr. Winfred Parnell is a board-certified physician in obstetrics and gynecologic care.
  • Dr. Parnell noted, “I am honored to join the board of Aspira.

Dr. Ari Sareli to Lead Clinical Efforts for Memorial Healthcare System as Chief Medical Officer

Retrieved on: 
Thursday, March 23, 2023

HOLLYWOOD, Fla., March 23, 2023 /PRNewswire-PRWeb/ -- Dr. Aharon (Ari) Sareli, a critical care physician and longtime clinical and executive leader, has been named chief medical officer by Memorial Healthcare System. In a related move, Memorial appointed Dr. Holly Neville its associate chief medical officer.

Key Points: 
  • Sareli, along with Dr. Holly Neville in an associate CMO role, bring current, front-line experience to executive leadership positions
    HOLLYWOOD, Fla., March 23, 2023 /PRNewswire-PRWeb/ -- Dr. Aharon (Ari) Sareli, a critical care physician and longtime clinical and executive leader, has been named chief medical officer by Memorial Healthcare System .
  • In a related move, Memorial appointed Dr. Holly Neville its associate chief medical officer.
  • "Both Ari and Holly have worked throughout our system, earning respect and elevating patient care through collaborations with fellow physicians, nurses, and operational teams," said K. Scott Wester, Memorial Healthcare System CEO.
  • He was appointed director of Memorial Hospital West's Critical Care in 2010 and chief of critical care for the system in 2012.

Work-life center supports healthcare worker well-being after experiencing adverse event

Retrieved on: 
Thursday, March 23, 2023

OAKBROOK TERRACE, Illinois, March 23, 2023 (GLOBE NEWSWIRE) -- With an already distressed healthcare workforce demonstrating high levels of burnout, depression and suicide, access to behavioral healthcare, particularly after experiencing an adverse event, is critical.

Key Points: 
  • OAKBROOK TERRACE, Illinois, March 23, 2023 (GLOBE NEWSWIRE) -- With an already distressed healthcare workforce demonstrating high levels of burnout, depression and suicide, access to behavioral healthcare, particularly after experiencing an adverse event, is critical.
  • Step three: Develop a strategic change vision by implementing a crisis response plan, peer support program and work-life center.
  • Step five: Remove barriers by decreasing startup costs, ensuring convenient accessibility to work-life center and assuring confidentiality.
  • Step six: Generate short-term wins with the work-life center grand opening, sharing employee coaching and counseling experiences, and reporting statistics showing rapid adoption of services.

Transcarent Announces Randy K. Hawkins, M.D. as Chief Medical Officer

Retrieved on: 
Thursday, March 16, 2023

Transcarent , a health and care experience company that makes it easy for people to access high-quality, affordable care announced today that Dr. Randy Hawkins has joined the organization as Chief Medical Officer.

Key Points: 
  • Transcarent , a health and care experience company that makes it easy for people to access high-quality, affordable care announced today that Dr. Randy Hawkins has joined the organization as Chief Medical Officer.
  • Reporting to Transcarent Chief Executive Officer, Glen Tullman, Dr. Hawkins will oversee the organization’s clinical quality initiatives and support the organization’s health analytics strategy.
  • Dr. Hawkins joins Transcarent from Carrum where he was the Chief Medical Officer.
  • Previously, he served as Chief Medical Officer and EVP, Health Analytics at ConsumerMedical and he has also served in other senior clinical roles over his career at Connance, Glytec, and PatientKeeper, where he focused on patient safety and interoperability as their Chief Medical Information Officer.

The Inner Circle Acknowledges Masha Sachenko as a Distinguished Healthcare Professional for her contributions to Obstetrics and Gynecology

Retrieved on: 
Thursday, March 2, 2023

WELLINGTON, Fla., March 2, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Masha Sachenko is acknowledged as a Distinguished Healthcare Professional for her contributions to Obstetrics and Gynecology.

Key Points: 
  • WELLINGTON, Fla., March 2, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Masha Sachenko is acknowledged as a Distinguished Healthcare Professional for her contributions to Obstetrics and Gynecology.
  • She completed a residency in obstetrics and gynecology at Orlando Health Winnie Palmer Hospital for Women & Babies.
  • The doctor is board certified in obstetrics and gynecology by the American Board of Obstetrics and Gynecology (ABOG).
  • Obstetrics and Gynecology is the medical specialty that encompasses the two subspecialties of obstetrics and gynecology.

Study of Parkinson's Disease Genetics in Black and African American Populations Expands with Two Additional Sites

Retrieved on: 
Monday, February 27, 2023

"The BLAAC PD study is an opportunity for Black and African American people to participate in the pursuit of cures for Parkinson's — the fastest growing neurological disease — for themselves, their children and their community.

Key Points: 
  • "The BLAAC PD study is an opportunity for Black and African American people to participate in the pursuit of cures for Parkinson's — the fastest growing neurological disease — for themselves, their children and their community.
  • The study is recruiting volunteers from the Black or African American community — people with Parkinson's disease and people without the disease or a family history of Parkinson's (control participants).
  • "We are grateful to the participant and clinical site partners building this study to learn more about Parkinson's-linked genetic changes in Black and African American populations toward better treatments for all."
  • Fox Foundation supports additional efforts — some feeding to GP2 — to explore population-specific genetics, clinical disease experience, and access to care.

Xavier University of Louisiana and Ochsner Health Partner to Create College of Medicine and Pursue Health, Educational Equity

Retrieved on: 
Tuesday, January 17, 2023

NEW ORLEANS, Jan. 17, 2023 /PRNewswire/ -- Xavier University of Louisiana (Xavier) and Ochsner Health (Ochsner) today announced an agreement to establish a joint College of Medicine. The two institutions will create a strong physician pipeline that addresses longstanding inequities within the nation's health care system and builds the health care workforce of the future. By anchoring their partnership with a College of Medicine, Xavier and Ochsner affirm their legacy of advancing health care excellence and education for the next generation, bringing new opportunities to marginalized populations in Louisiana and the United States.

Key Points: 
  • The Partnership Will Create a New, Standalone College of Medicine in New Orleans, Training the Health Care Professionals of Tomorrow
    NEW ORLEANS, Jan. 17, 2023 /PRNewswire/ -- Xavier University of Louisiana (Xavier) and Ochsner Health (Ochsner) today announced an agreement to establish a joint College of Medicine.
  • To launch the College of Medicine, Ochsner and Xavier will form a nonprofit corporation, create a new curriculum and use facilities, personnel, and administrative processes of both institutions.
  • The new College of Medicine will be governed by a board of directors nominated by Ochsner and Xavier, with each institution appointing an equal number of directors.
  • Ochsner Health and Xavier again forged partnerships to improve health equity through new graduate programs in health sciences and the establishment of the Ochsner Health and Xavier University Institute for Health Equity and Research (OXIHER) .